unc-17 Antibody

Here’s a structured FAQ collection for researchers working with unc-17 antibodies in C. elegans studies, based on methodological challenges, experimental design, and data interpretation:

How do I validate the specificity of an anti-UNC-17 antibody for immunofluorescence?

Methodological Answer:

• Controls Required:

  • Negative controls: Use unc-17 null mutants (e.g., e245 with G347R missense mutation) to confirm loss of signal .

  • Positive controls: Compare staining in wild-type (N2) and rescue strains (e.g., transgenic unc-17 overexpression) .

• Co-staining: Pair with cholinergic neuron markers (e.g., cho-1::gfp or ChAT antibodies) to confirm expression in known UNC-17-positive cells .

• Quantitative Validation: Use confocal microscopy with standardized acquisition parameters (e.g., non-saturated pixel intensity) and blind analysis to compare nerve ring staining intensities .

Example Data Table:

What are the key applications of UNC-17 antibodies in studying synaptic function?

Methodological Answer:

• Vesicular Localization: Use immunoelectron microscopy to confirm UNC-17’s presence on synaptic vesicles (MAb1403 validated for this) .

• Phenotypic Rescue Assays: Quantify locomotion recovery in unc-17(e245) mutants crossed with suppressors (e.g., sup-1, sup-2, sup-8) .

• Drug Sensitivity: Measure aldicarb resistance (AChE inhibitor) to assess presynaptic ACh release efficiency .

Key Finding:
unc-17(e245); sup-1(e995) shows 70% recovery in swimming behavior compared to wild-type .

How to design experiments resolving contradictory UNC-17 staining intensities across studies?

Methodological Answer:

• Variable Fixation Protocols: Compare methanol/acetone vs. paraformaldehyde fixation (e.g., Mullen et al. 2006 vs. Duerr et al. 2008) .

• Antibody Batch Effects: Test multiple antibody lots (e.g., mAb1403 vs. polyclonal R383) .

• Genetic Backgrounds: Account for modifiers (e.g., unc-104 mutants impair UNC-17 transport, altering staining patterns) .

Data Conflict Resolution Workflow:

• Replicate staining in a cho-1::gfp; unc-104 background to isolate UNC-17 retention in cell bodies .

• Normalize intensity to internal controls (e.g., ChAT or synaptobrevin) .

What mechanisms explain allele-specific suppression of unc-17(e245)?

Methodological Answer:

• Charge Compensation: The e245 G347R mutation introduces a positive charge in UNC-17’s transmembrane domain. Dominant suppressors (e.g., sup-8/snb-1(I97D)) introduce acidic residues for electrostatic interaction .

• Functional Redundancy: Test paralogs (e.g., erd-2.1 vs. erd-2.2) using RNAi in suppressor backgrounds to assess synthetic lethality .

Experimental Design:

How to optimize UNC-17 antibody protocols for ultrastructural analysis?

Methodological Answer:

• Pre-embedding Immunogold: Use MAb1403 at 1:500 dilution with 1% glutaraldehyde fixation for synaptic vesicle localization .

• Quantitative Analysis: Count gold particles/µm² in cholinergic vs. non-cholinergic synapses (wild-type baseline: 12 ± 2 particles/µm²) .

Troubleshooting:

• If background is high, block with 5% BSA + 0.1% saponin for 2 hr before primary antibody incubation .